<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Physiol.</journal-id>
<journal-title>Frontiers in Physiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Physiol.</abbrev-journal-title>
<issn pub-type="epub">1664-042X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fphys.2017.00086</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Physiology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Two Phase Modulation of <inline-formula><mml:math id="M1"><mml:mrow><mml:msubsup><mml:mrow><mml:mtext>NH</mml:mtext></mml:mrow><mml:mn>4</mml:mn><mml:mo>+</mml:mo></mml:msubsup></mml:mrow></mml:math></inline-formula> Entry and Cl<sup>&#x02212;</sup>/<inline-formula><mml:math id="M2"><mml:mrow><mml:msubsup><mml:mrow><mml:mtext>HCO</mml:mtext></mml:mrow><mml:mn>3</mml:mn><mml:mo>-</mml:mo></mml:msubsup></mml:mrow></mml:math></inline-formula> Exchanger in Submandibular Glands Cells by Dexmedetomidine</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Ji</surname> <given-names>Minjeong</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/380607/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Park</surname> <given-names>Chul-Kyu</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/274456/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Lee</surname> <given-names>Jin Woo</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Park</surname> <given-names>Kook Yang</given-names></name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Son</surname> <given-names>Kuk Hui</given-names></name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<xref ref-type="author-notes" rid="fn001"><sup>&#x0002A;</sup></xref>
<xref ref-type="author-notes" rid="fn004"><sup>&#x02020;</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Hong</surname> <given-names>Jeong Hee</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="author-notes" rid="fn002"><sup>&#x0002A;</sup></xref>
<xref ref-type="author-notes" rid="fn004"><sup>&#x02020;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/254825/overview"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Department of Physiology, Lee Gil Ya Cancer and Diabetes Institute, College of Medicine, Gachon University</institution> <country>Incheon, South Korea</country></aff>
<aff id="aff2"><sup>2</sup><institution>Department of Molecular Medicine, School of Medicine, Lee Gil Ya Cancer and Diabetes Institute, Gachon University</institution> <country>Incheon, South Korea</country></aff>
<aff id="aff3"><sup>3</sup><institution>Department of Thoracic and Cardiovascular Surgery, Gachon University Gil Medical Center, Gachon University</institution> <country>Incheon, South Korea</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: Francisco Javier Alvarez-Leefmans, Wright State University, USA</p></fn>
<fn fn-type="edited-by"><p>Reviewed by: Dandan Sun, University of Pittsburgh, USA; Marcelo Catalan, National Institute of Dental and Craniofacial Research (NIH), USA</p></fn>
<fn fn-type="corresp" id="fn001"><p>&#x0002A;Correspondence: Kuk Hui Son <email>dr632&#x00040;gilhospital.com</email></p></fn>
<fn fn-type="corresp" id="fn002"><p>Jeong Hee Hong <email>minicleo&#x00040;gachon.ac.kr</email></p></fn>
<fn fn-type="other" id="fn003"><p>This article was submitted to Membrane Physiology and Membrane Biophysics, a section of the journal Frontiers in Physiology</p></fn>
<fn fn-type="other" id="fn004"><p>&#x02020;These authors have contributed equally to this work.</p></fn></author-notes>
<pub-date pub-type="epub">
<day>01</day>
<month>03</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="collection">
<year>2017</year>
</pub-date>
<volume>8</volume>
<elocation-id>86</elocation-id>
<history>
<date date-type="received">
<day>27</day>
<month>07</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>30</day>
<month>01</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2017 Ji, Park, Lee, Park, Son and Hong.</copyright-statement>
<copyright-year>2017</copyright-year>
<copyright-holder>Ji, Park, Lee, Park, Son and Hong</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<abstract><p>Dexmedetomidine (Dex), a highly selective &#x003B1;2-adrenoceptor agonist, attenuates inflammatory responses induced by lipopolysaccharide (LPS) and induces sedative and analgesic effects. Administration of Dex also reduces salivary secretion in human subjects and inhibits osmotic water permeability in rat cortical collecting ducts. However, little is known about the mechanisms underlying the effects of Dex on salivary glands fluid secretion. We demonstrated the &#x003B1;2-adrenoceptor expression in the basolateral membrane of mouse submandibular glands (SMG). To investigate fluid secretion upon treatment with Dex, we studied the effects of Dex on the activity of Na<sup>&#x0002B;</sup>-K<sup>&#x0002B;</sup>-2Cl<sup>&#x02212;</sup> cotransporter1 (NKCC1) and Cl<sup>&#x02212;</sup>/<inline-formula><mml:math id="M3"><mml:mrow><mml:msubsup><mml:mrow><mml:mtext>HCO</mml:mtext></mml:mrow><mml:mn>3</mml:mn><mml:mo>-</mml:mo></mml:msubsup></mml:mrow></mml:math></inline-formula> exchange (CBE), and on downstream pro-inflammatory cytokine expression in isolated primary mouse SMG cells. Dex acutely increased CBE activity and NKCC1-mediated and independent <inline-formula><mml:math id="M4"><mml:mrow><mml:msubsup><mml:mrow><mml:mtext>NH</mml:mtext></mml:mrow><mml:mn>4</mml:mn><mml:mo>+</mml:mo></mml:msubsup></mml:mrow></mml:math></inline-formula> entry in SMG duct cells, and enhanced ductal fluid secretion in a sealed duct system. Dex showed differential effects on cholinergic/adrenergic stimulations and inflammatory mediators, histamine, and LPS, stimulations-induced Ca<sup>2&#x0002B;</sup> in mouse SMG cells. Both, histamine- and LPS-induced intracellular Ca<sup>2&#x0002B;</sup> increases were inhibited by Dex, whereas carbachol-stimulated Ca<sup>2&#x0002B;</sup> signals were not. Long-lasting (2 h) treatment with Dex reduced CBE activity in SMG and in human submandibular glands (HSG) cells. Moreover, when isolated SMG cells were stimulated with Dex for 2 h, phosphodiesterase 4D (PDE4D) expression was enhanced. These results confirm the anti-inflammatory properties of Dex on LPS-mediated signaling. Further, Dex also inhibited mRNA expression of interleukin-6 and NADPH oxidase 4. The present study also showed that &#x003B1;2-adrenoceptor activation by Dex reduces salivary glands fluid secretion by increasing PDE4D expression, and subsequently reducing the concentration of cAMP. These findings reveal an interaction between the &#x003B1;2-adrenoceptor and PDE4D, which should be considered when using &#x003B1;2-adrenoceptor agonists as sedative or analgesics.</p></abstract>
<kwd-group>
<kwd>dexmedetomidine</kwd>
<kwd>secretion</kwd>
<kwd>ion transporters</kwd>
<kwd>submandibular gland</kwd>
<kwd>phosphodiesterase 4</kwd>
</kwd-group>
<contract-sponsor id="cn001">National Research Foundation of Korea<named-content content-type="fundref-id">10.13039/501100003725</named-content></contract-sponsor>
<contract-sponsor id="cn002">Ministry of Science, ICT and Future Planning<named-content content-type="fundref-id">10.13039/501100003621</named-content></contract-sponsor>
<contract-sponsor id="cn003">Korea Health Industry Development Institute<named-content content-type="fundref-id">10.13039/501100003710</named-content></contract-sponsor>
<contract-sponsor id="cn004">Ministry of Health and Welfare<named-content content-type="fundref-id">10.13039/501100003625</named-content></contract-sponsor>
<counts>
<fig-count count="8"/>
<table-count count="1"/>
<equation-count count="0"/>
<ref-count count="41"/>
<page-count count="12"/>
<word-count count="7375"/>
</counts>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="s1">
<title>Introduction</title>
<p>Dexmedetomidine (Dex) is a selective &#x003B1;2-adrenoceptor agonist with sedative, analgesic, anxiolytic, and hemodynamic stabilizing properties and has protective effects on systemic inflammation by attenuating oxidative stress (Kili&#x000E7; et al., <xref ref-type="bibr" rid="B15">2012</xref>; Shen et al., <xref ref-type="bibr" rid="B32">2013</xref>). Several studies have shown that Dex benefits various organs, including the heart (Okada et al., <xref ref-type="bibr" rid="B24">2007</xref>; Kocoglu et al., <xref ref-type="bibr" rid="B16">2008</xref>), kidney (Liu et al., <xref ref-type="bibr" rid="B19">2016</xref>), intestine (Sun et al., <xref ref-type="bibr" rid="B34">2015</xref>), and brain (Engelhard et al., <xref ref-type="bibr" rid="B5">2002</xref>). Moreover, Dex exerts its protective effects by inhibiting interleukin (IL)-1&#x003B2;-induced IL-6 synthesis (Tanabe et al., <xref ref-type="bibr" rid="B35">2014</xref>) and by reducing of lipopolysaccharide (LPS)-induced production of pro-inflammatory cytokines, such as IL-1&#x003B2; and IL-6 (Peng et al., <xref ref-type="bibr" rid="B27">2013</xref>). Previously, we demonstrated that Dex attenuated histamine-induced Ca<sup>2&#x0002B;</sup> increase and IL-6 expression in human salivary glands (HSG) cells (Yang and Hong, <xref ref-type="bibr" rid="B40">2015</xref>). Although, Dex reduces inflammation, there are side effects associated with it, such as reduced salivary secretion (Karhuvaara et al., <xref ref-type="bibr" rid="B14">1991</xref>; Bischoff and Kochs, <xref ref-type="bibr" rid="B2">1993</xref>) and prevented hypersecretion (Marks et al., <xref ref-type="bibr" rid="B21">2010</xref>). Monoxidine, a &#x003B1;2-adrenoceptor and imidazole agonist, mediates salivary glands vasoconstriction leading to hyposalivation (Moreira et al., <xref ref-type="bibr" rid="B22">2013</xref>). Activation of &#x003B1;2-adrenoceptors inhibits adenylate cyclase, thereby reducing cAMP accumulation and cAMP-dependent protein kinase signaling (Rabin et al., <xref ref-type="bibr" rid="B28">1997</xref>).</p>
<p>Fluid secretion and transport are regulated by multiple inputs, such as neurotransmitters-induced Ca<sup>2&#x0002B;</sup> and cAMP levels in acinar cells (Lee et al., <xref ref-type="bibr" rid="B18">2012</xref>). However, little is known about the regulatory effects of Dex on salivary glands function. Elevation of Ca<sup>2&#x0002B;</sup> levels by neuronal inputs, such as acetylcholine, stimulate fluid secretion by increasing luminal efflux of Cl<sup>&#x02212;</sup> through Ca<sup>2&#x0002B;</sup>-activated Cl<sup>&#x02212;</sup> channels. Cl<sup>&#x02212;</sup> influx into the cytoplasm occurs against its electrochemical gradient via the basolateral Na<sup>&#x0002B;</sup>-K<sup>&#x0002B;</sup>-2Cl<sup>&#x02212;</sup> co-transporter 1 (NKCC1) and via equivalent activities of the Na<sup>&#x0002B;</sup>-H<sup>&#x0002B;</sup> exchanger and the Cl<sup>&#x02212;</sup>-<inline-formula><mml:math id="M5"><mml:mrow><mml:msubsup><mml:mrow><mml:mtext>HCO</mml:mtext></mml:mrow><mml:mn>3</mml:mn><mml:mo>-</mml:mo></mml:msubsup></mml:mrow></mml:math></inline-formula> exchanger (Lee et al., <xref ref-type="bibr" rid="B18">2012</xref>). <inline-formula><mml:math id="M6"><mml:mrow><mml:msubsup><mml:mrow><mml:mtext>HCO</mml:mtext></mml:mrow><mml:mn>3</mml:mn><mml:mo>-</mml:mo></mml:msubsup></mml:mrow></mml:math></inline-formula> transport in the salivary glands requires basolateral <inline-formula><mml:math id="M7"><mml:mrow><mml:msubsup><mml:mrow><mml:mtext>HCO</mml:mtext></mml:mrow><mml:mn>3</mml:mn><mml:mo>-</mml:mo></mml:msubsup></mml:mrow></mml:math></inline-formula> input via the Na<sup>&#x0002B;</sup>-<inline-formula><mml:math id="M8"><mml:mrow><mml:msubsup><mml:mrow><mml:mtext>HCO</mml:mtext></mml:mrow><mml:mn>3</mml:mn><mml:mo>-</mml:mo></mml:msubsup></mml:mrow></mml:math></inline-formula> co-transporter and subsequent luminal <inline-formula><mml:math id="M9"><mml:mrow><mml:msubsup><mml:mrow><mml:mtext>HCO</mml:mtext></mml:mrow><mml:mn>3</mml:mn><mml:mo>-</mml:mo></mml:msubsup></mml:mrow></mml:math></inline-formula> output through solute carrier transport 26 (SLC26) superfamily proteins, such as SLC26A6 (Lee et al., <xref ref-type="bibr" rid="B18">2012</xref>; Jeong and Hong, <xref ref-type="bibr" rid="B13">2016</xref>). The Ca<sup>2&#x0002B;</sup> and cAMP signaling pathways synergistically regulate fluid and <inline-formula><mml:math id="M10"><mml:mrow><mml:msubsup><mml:mrow><mml:mtext>HCO</mml:mtext></mml:mrow><mml:mn>3</mml:mn><mml:mo>-</mml:mo></mml:msubsup></mml:mrow></mml:math></inline-formula> secretion as a common signaling synergism (Lee et al., <xref ref-type="bibr" rid="B18">2012</xref>; Hong et al., <xref ref-type="bibr" rid="B12">2014</xref>). Synergistic regulation of Ca<sup>2&#x0002B;</sup> and cAMP resulted in the activation of ion transporters, which induce changes in intracellular pH (pH<sub>i</sub>; Park et al., <xref ref-type="bibr" rid="B26">2013</xref>)</p>
<p>Phosphodiesterase (PDE) reduces intracellular cAMP and cGMP concentrations (Omori and Kotera, <xref ref-type="bibr" rid="B25">2007</xref>). In the salivary glands, PDE4 is involved in the release of amylase from parotid acinar cells (Satoh et al., <xref ref-type="bibr" rid="B31">2009</xref>). The PDE4 inhibitor rolipram regulates ductal <inline-formula><mml:math id="M11"><mml:mrow><mml:msubsup><mml:mrow><mml:mtext>HCO</mml:mtext></mml:mrow><mml:mn>3</mml:mn><mml:mo>-</mml:mo></mml:msubsup></mml:mrow></mml:math></inline-formula> secretion and confers a protective effect on lipopolysaccharide (LPS)-induced Ca<sup>2&#x0002B;</sup> signaling and inflammatory cytokine expression (Lee et al., <xref ref-type="bibr" rid="B17">2016</xref>). Although, it has been suggested that Dex is involved in cAMP-mediated cellular events (Rouch et al., <xref ref-type="bibr" rid="B30">1997</xref>), it is unknown whether Dex-modulation of cAMP levels plays a role in ion transporter activity during salivary secretion or whether Dex modulates expression of cAMP-dependent PDE4 of the salivary glands.</p>
<p>LPS is a characteristic component of the outer membrane of Gram-negative bacteria, and LPS triggers innate immune responses to wide range of pathogens by binding to Toll-like receptor 4 (TLR4; Dauphinee and Karsan, <xref ref-type="bibr" rid="B4">2006</xref>). Enhanced expression of TLRs in salivary tissue is associated with progression of inflammatory reactions in autoimmune diseases, such as Sj&#x000F6;gren&#x00027;s syndrome (Spachidou et al., <xref ref-type="bibr" rid="B33">2007</xref>). Moreover, TLR activation triggered by LPS enhances oxidative signaling (Liu et al., <xref ref-type="bibr" rid="B20">2015</xref>). Oxidative stress is closely related to inflammation, which is a risk factor in oral disease. It is important that patients with chronic kidney disease report oral complications, such as dry mouth (Ersson et al., <xref ref-type="bibr" rid="B6">2011</xref>), as it may be an indicator of salivary glands dysfunction due to oxidative stress. The regulatory effects of Dex on ion transporters and on fluid secretion from the salivary glands during LPS exposure remain unclear.</p>
<p>We hypothesized that Dex could protect against LPS-induced inflammatory signaling. Therefore, we investigated the anti-inflammatory properties of Dex associated with Ca<sup>2&#x0002B;</sup> signaling in salivary glands acini and ductal cells upon exposure to <italic>Porphyromonas gingivalis</italic> LPS. We also determined whether Dex has regulatory effects on the ion transporters that mediate fluid secretion and on the cAMP-PDE axis. An understanding of the mechanisms underlying the reduced fluid secretion upon Dex treatment may lead to innovative strategies for the treatment of inflammation and salivary glands dysfunction during anesthesia without additional unwanted side effects.</p></sec>
<sec sec-type="materials and methods" id="s2">
<title>Materials and methods</title>
<sec>
<title>Reagents and DNA plasmids</title>
<p>Fura2-acetoxymethyl ester (Fura2-AM) and 2&#x02032;,7&#x02032;-bis-(carboxyethyl)-5-(and-6)-carboxyfluorescein (BCECF)-AM were purchased from Teflabs (Austin, TX). LPS from <italic>P. gingivalis</italic>, histamine, Dexmedetomidine hydrochloride (Dex), isoproterenol, carbamyl choline chloride (CCh), yohimbine (YOH), bumetanide (Bumeta), and all other chemicals not mentioned here were purchased from Sigma Aldrich (St. Louis, MO). Pluronic F-127 (20% in DMSO) and ZO-1 antibody were purchased from Invitrogen (Carlsbad, CA). PDE4 was purchased from Fabgennix (Frisco, TX), and IL-6 and caspase-1 antibodies were purchased from Abcam (Cambridge, MA). The &#x003B1;2<sub>A</sub>-adrenergic receptor antibody was purchased from Santacruz Inc. (Santa Cruz, CA). Collagenase P was purchased from Roche (Basel, Switzerland). The HA-tagged human AE2, pCMV6-AC-mKate-SLC26A6, and empty vectors were kindly provided by Dr. Shmuel Muallem (National Institutes of Health, Bethesda, MD, USA).</p></sec>
<sec>
<title>Isolation of mouse submandibular glands cells and cultures of parotid sealed ducts and human salivary glands cell lines</title>
<p>All procedures for maintaining the mice and for the isolation of acini and ducts followed Gachon University guidelines and were approved by the Animal Care and Use Committee of Gachon University. Cultured, sealed parotid ducts from wild-type were prepared as described previously (Hong et al., <xref ref-type="bibr" rid="B11">2015</xref>). SMG isolated from 20 to 25 g wild-type mice were washed and resuspended in physiological salt solution (PSS) A containing 140 mM NaCl, 10 mM glucose, 1 mM MgCl<sub>2</sub>, 5 mM KCl, 10 mM HEPES, and 1 mM CaCl<sub>2</sub>, pH 7.4, 0.02% STI, 0.1% sodium pyruvate, and 0.1% BSA (called PSA) and kept on ice until use. Briefly, the minced SMG was incubated in PSA containing 2.5 mg/10 ml collagenase P (Roche) for 8 min at 37&#x000B0;C. The digest was washed and resuspended with PSA, and kept on ice until use. For the culture of sealed ducts, C57BL/6N wild-type mice (20&#x02013;25 g) were killed by cervical dislocation. The parotid glands were removed and injected with a digestion buffer consisting of serum-free DMEM, containing 50 U/ml collagenase, 400 U/ml hyaluronidase, 0.2 mg/ml soybean trypsin inhibitor (STI), and 2 mg/ml bovine serum albumin (BSA). The tissue was minced and incubated at 37&#x000B0;C for 30 min and then in fresh digestion buffer for a further 45 min. After a wash with DMEM containing 3% BSA and 0.2 mg/ml STI, ducts were microdissected from the partially digested tissue to remove acini or connective tissues. The ducts were cultured in DMEM supplemented with 10% fetal bovine serum at 37&#x000B0;C for 24 h before use. The HSG cells were purchased from American Type Culture Collection (Rockville, MD) and maintained in DMEM containing 10% FBS with antibiotics including 100 U/ml penicillin and 100 &#x003BC;g/ml streptomycin at 37&#x000B0;C in a cell culture incubator with 5% CO<sub>2</sub>/95% air atmosphere. When cells were 70&#x0007E;80% confluent, they were washed with PBS and dispersed with a 2 min trypsin/EDTA treatment before they were transferred to new culture dishes or glass coverslips-including dishes for later use.</p></sec>
<sec>
<title>Measurement of fluid secretion by the sealed ducts</title>
<p>Ductal fluid secretion was measured by video microscopy as previously described (Yang et al., <xref ref-type="bibr" rid="B41">2009</xref>; Hong et al., <xref ref-type="bibr" rid="B11">2015</xref>). Briefly, the sealed ducts were transferred to a poly-L-lysine-coated perfusion chamber and perfused with HEPES- and then <inline-formula><mml:math id="M12"><mml:mrow><mml:msubsup><mml:mrow><mml:mtext>HCO</mml:mtext></mml:mrow><mml:mn>3</mml:mn><mml:mo>-</mml:mo></mml:msubsup></mml:mrow></mml:math></inline-formula>-buffered media and stimulated with 5 &#x003BC;M forskolin in <inline-formula><mml:math id="M13"><mml:mrow><mml:msubsup><mml:mrow><mml:mtext>HCO</mml:mtext></mml:mrow><mml:mn>3</mml:mn><mml:mo>-</mml:mo></mml:msubsup></mml:mrow></mml:math></inline-formula>-buffered media. Images were captured at 2 min intervals, obtained up to 40 min, and analyzed by calculating the lumen volume. Due to the variation in size between the microdissected ducts, a normalized procedure was used with the volume of the first image (V<sub>0</sub>) set as 1. Fluid secretion was represented as the ratio V<sub>t</sub>/V<sub>0</sub>, which was calculated from V<sub>t</sub>/V<sub>0</sub> &#x0003D; (A<sub>t</sub>/A<sub>0</sub>)<sup>3/2</sup>.</p></sec>
<sec>
<title>DNA transfection</title>
<p>Plasmid DNA transfection by Lipofectamine 2000 was followed by manufacturer&#x00027;s protocol (Invitrogen). Each plasmid DNA was diluted in 250 &#x003BC;l of Opti-Eagle&#x00027;s Minimum Essential Media (Opti-MEM&#x02122;, Invitrogen), and 4 &#x003BC;l Lipofectamine 2000 was diluted in 250 &#x003BC;l of the same medium and incubated for 5 min at room temperature. The DNAs and Lipofectamine 2000 were mixed and after 25 min were added to the cell-cultured dish containing glass coverslip. After 4 h, the medium was replaced with a fresh DMEM medium containing FBS and the cells were used 24 h after the beginning of the transfection.</p></sec>
<sec>
<title>Measurement of intracellular Ca<sup>2&#x0002B;</sup> concentration</title>
<p>All procedures for mouse maintenance and for the isolation of submandibular and parotid acini and ducts followed Gachon University guidelines and were approved by the Animal Care and Use Committee of Gachon University. Salivary glands isolated from 25 to 30 g C57BL/6N mice were washed and re-suspended in PSA and kept on ice until use. Briefly, minced salivary gland cells were incubated in PSA containing 2.5 mg/10 ml collagenase P for 8 min at 37&#x000B0;C. The digest was washed with PSA, re-suspended in PSA, and kept on ice until use. Cells were transferred onto cover glasses and incubated with 4 &#x003BC;M Fura2-AM in the presence of 0.05% Pluronic F-127 for 30 min in PSS at room temperature, and then washed with PSS. Changes in intracellular Ca<sup>2&#x0002B;</sup> concentration ([Ca<sup>2&#x0002B;</sup>]<sub>i</sub>) were determined by measuring the fluorescence intensities using dual excitation wavelengths of 340 and 380 nm and an emission wavelength of 510 nm. Results are presented as fluorescence ratios (Ratio &#x0003D; <italic>F</italic><sub>340/380</sub>). The emitted fluorescence was monitored with a CCD camera (Photometrics, AZ) attached to an inverted microscope (Olympus, Japan) and analyzed with a MetaFluor system (Molecular Devices, PA). Fluorescence images were obtained at 1 s intervals and background fluorescence was subtracted from raw background signals at each wavelength.</p></sec>
<sec>
<title>Measurement of Cl<sup>&#x02212;</sup>-<inline-formula><mml:math id="M14"><mml:mrow><mml:msubsup><mml:mrow><mml:mtext>HCO</mml:mtext></mml:mrow><mml:mn>3</mml:mn><mml:mo>-</mml:mo></mml:msubsup></mml:mrow></mml:math></inline-formula> exchange activity and <inline-formula><mml:math id="M15"><mml:mrow><mml:msubsup><mml:mrow><mml:mtext>NH</mml:mtext></mml:mrow><mml:mn>4</mml:mn><mml:mo>+</mml:mo></mml:msubsup></mml:mrow></mml:math></inline-formula> influx by pH<sub>i</sub></title>
<p>Changes in pH<sub>i</sub> were measured with BCECF-AM at dual excitation wavelengths of 440 and 495 nm and an emission wavelength of 530 nm. Isolated SMG cells attached onto coverslips were loaded in the chamber with 6 &#x003BC;M BCECF-AM in the presence of 0.05% Pluronic F-127 for 15 min at room temperature. After stabilizing the fluorescence, the cells were perfused with PSS for at least 5 min before measuring pH<sub>i</sub> at 37&#x000B0;C. CBE activity was measured by incubating the cells with CO<sub>2</sub>-saturated <inline-formula><mml:math id="M16"><mml:mrow><mml:msubsup><mml:mrow><mml:mtext>HCO</mml:mtext></mml:mrow><mml:mn>3</mml:mn><mml:mo>-</mml:mo></mml:msubsup></mml:mrow></mml:math></inline-formula>-buffered media to acidify the cytosol and initiated by perfusing the cells with Cl<sup>&#x02212;</sup>-free <inline-formula><mml:math id="M17"><mml:mrow><mml:msubsup><mml:mrow><mml:mtext>HCO</mml:mtext></mml:mrow><mml:mn>3</mml:mn><mml:mo>-</mml:mo></mml:msubsup></mml:mrow></mml:math></inline-formula>-buffered media. The emitted fluorescence was monitored with a CCD camera (Photometrics) attached to an inverted microscope (Olympus, Japan) and analyzed with a MetaFluor system (Molecular Devices). All fluorescence images were obtained at 1 s intervals and background fluorescence was subtracted from raw background signals at each wavelength. CBE activity was determined from the derivatives of the slopes from the first 30&#x02013;45 s of pH<sub>i</sub> increases in Cl<sup>&#x02212;</sup>-free <inline-formula><mml:math id="M18"><mml:mrow><mml:msubsup><mml:mrow><mml:mtext>HCO</mml:mtext></mml:mrow><mml:mn>3</mml:mn><mml:mo>-</mml:mo></mml:msubsup></mml:mrow></mml:math></inline-formula>-buffered media. <inline-formula><mml:math id="M19"><mml:mrow><mml:msubsup><mml:mrow><mml:mtext>NH</mml:mtext></mml:mrow><mml:mn>4</mml:mn><mml:mo>+</mml:mo></mml:msubsup></mml:mrow></mml:math></inline-formula> influx was measured from the rate of pH<sub>i</sub> decrease induced by intracellular uptake of <inline-formula><mml:math id="M20"><mml:mrow><mml:msubsup><mml:mrow><mml:mtext>NH</mml:mtext></mml:mrow><mml:mn>4</mml:mn><mml:mo>+</mml:mo></mml:msubsup></mml:mrow></mml:math></inline-formula> as previously described (Evans and Turner, <xref ref-type="bibr" rid="B7">1997</xref>; Worrell et al., <xref ref-type="bibr" rid="B39">2004</xref>). Administration of NH<sub>4</sub>Cl in the extracellular solution induced the initial alkalization by diffusion of NH<sub>3</sub>, and then pH<sub>i</sub> is decreased by <inline-formula><mml:math id="M21"><mml:mrow><mml:msubsup><mml:mrow><mml:mtext>NH</mml:mtext></mml:mrow><mml:mn>4</mml:mn><mml:mo>+</mml:mo></mml:msubsup></mml:mrow></mml:math></inline-formula> influx as a substitution of K<sup>&#x0002B;</sup>. The pH<sub>i</sub> recovery rate in second phase provides <inline-formula><mml:math id="M22"><mml:mrow><mml:msubsup><mml:mrow><mml:mtext>NH</mml:mtext></mml:mrow><mml:mn>4</mml:mn><mml:mo>+</mml:mo></mml:msubsup></mml:mrow></mml:math></inline-formula> influx. The traces were normalized at time point of administration of NH<sub>4</sub>Cl. The acidified slope was calculated and represented as the ratio.</p></sec>
<sec>
<title>Confocal imaging</title>
<p>Experiments were performed with isolated SMG acinar and ductal clusters. Isolated SMG acini and ducts were plated on glass coverslips for 5 min at room temperature prior to fixation with chilled methanol or 4% paraformaldehyde for 10 min. After fixation, immunostaining was performed as described previously (Lee et al., <xref ref-type="bibr" rid="B17">2016</xref>) using 1:100 dilutions of the &#x003B1;2<sub>A</sub>-adrenergic receptor, PDE4, and ZO-1 antibodies. Briefly, the cells were incubated with the primary antibodies overnight at 4&#x000B0;C, then washed with 5% BSA/PBS. Remaining bound antibodies were detected with goat anti-rabbit immunoglobulin G (IgG) tagged with fluorescein isothiocyanate (FITC) (ZO-1) or rhodamine (PDE4) and then washed with PBS. Coverslips were mounted on glass slides with Fluoromount-G<sup>TM</sup> (Electron Microscopy Sciences, Hatfield, PA) and analyzed using a LSM 700 Zeiss confocal microscope (Germany) with ZEN software. To determine the normalized intensity of PDE4 in each image, average intensity of PDE4 was divided by area. Images were collected from four to five separate preparations of acinar and ductal cells, and results are the averages from all experiments. The absence of a primary antibody was used as a negative control (NC). Fluorescent images were analyzed with a MetaMorph system (Molecular Devices).</p></sec>
<sec>
<title>Semi-quantitative reverse transcription-polymerase chain reaction (semi-qRT-PCR)</title>
<p>Total RNA was extracted from isolated SMG and HSG cells using the Hybrid-RiboEx extraction system (Gentaur, Belgium) following the manufacturer&#x00027;s instructions, and amplified according to the manufacturer&#x00027;s protocol using TOPscript&#x02122; RT-PCR kit from Enzynomics (Daejeon, South Korea) and nested primers. The primers used are listed in Table <xref ref-type="table" rid="T1">1</xref>. The PCR protocol comprised a denaturation step at 95&#x000B0;C for 5 min, followed by 35 cycles of 95&#x000B0;C for 1 min, an annealing step for 1 min, and an extension step at 72&#x000B0;C for 1 min, finally culminating with a final extension step at 72&#x000B0;C for 10 min. PCR products were electrophoresed on 1% agarose gels. Bands on agarose gels were visualized and acquired with a CCD camera and scanned using GelDoc<sup>XR</sup> imaging system (Bio-Rad, CA). Intensities of PCR bands were analyzed with a MetaMorph system (Molecular Devices).</p>
<table-wrap position="float" id="T1">
<label>Table 1</label>
<caption><p><bold>Information of primers</bold>.</p></caption>
<table frame="hsides" rules="groups">
<thead><tr>
<th valign="top" align="left"><bold>Genes</bold></th>
<th valign="top" align="center"><bold>Tm (&#x000B0;C)</bold></th>
<th valign="top" align="left"><bold>Sequences (5&#x02032; &#x02192; 3&#x02032;)</bold></th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">mPDE4A</td>
<td valign="top" align="center">55</td>
<td valign="top" align="left">(F) TTC AAG CTG CTG CAA GAA GA</td>
</tr>
<tr>
<td/>
<td/>
<td valign="top" align="left">(R) TTC CTG AGG ACC TGG ATA CG</td>
</tr>
<tr>
<td valign="top" align="left">mPDE4B</td>
<td valign="top" align="center">55</td>
<td valign="top" align="left">(F) GAA CAA ATG GGG CCT TAA CA</td>
</tr>
<tr>
<td/>
<td/>
<td valign="top" align="left">(R) TTG TCC AGG AGG AGA ACA CC</td>
</tr>
<tr>
<td valign="top" align="left">mPDE4C</td>
<td valign="top" align="center">57</td>
<td valign="top" align="left">(F) CAT GCT CAA CCG TGA GTT GT</td>
</tr>
<tr>
<td/>
<td/>
<td valign="top" align="left">(R) TGG AAC GTC TTG AGG AGG TC</td>
</tr>
<tr>
<td valign="top" align="left">mPDE4D</td>
<td valign="top" align="center">57</td>
<td valign="top" align="left">(F) GGA GCT TGT CAC CTT CTT GG</td>
</tr>
<tr>
<td/>
<td/>
<td valign="top" align="left">(R) GTG GGC TTT AAG TTG CTC CA</td>
</tr>
<tr>
<td valign="top" align="left">mGAPDH</td>
<td valign="top" align="center">55</td>
<td valign="top" align="left">(F) TTA GCC CCC CTG GCC AAG G</td>
</tr>
<tr>
<td/>
<td/>
<td valign="top" align="left">(R) CTT ACT CCT TGG AGG CCA TG</td>
</tr>
<tr>
<td valign="top" align="left">mIL-6</td>
<td valign="top" align="center">63</td>
<td valign="top" align="left">(F) GAG GAT ACC ACT CCC AAC AGA CC</td>
</tr>
<tr>
<td/>
<td/>
<td valign="top" align="left">(R) CTA TGG TAC TCC AGA AGA CCA GAG</td>
</tr>
<tr>
<td valign="top" align="left">mNOX2</td>
<td valign="top" align="center">57</td>
<td valign="top" align="left">(F) GTG TTG CTC GAC AAG GAT TC</td>
</tr>
<tr>
<td/>
<td/>
<td valign="top" align="left">(R) CTC CGA ATG GTT TTG GTA GAG</td>
</tr>
<tr>
<td valign="top" align="left">mNOX4</td>
<td valign="top" align="center">58</td>
<td valign="top" align="left">(F) CAG CTT CTA CCT ACG CAA TAA G</td>
</tr>
<tr>
<td/>
<td/>
<td valign="top" align="left">(R) GGA AAT GAG CTT GGA ACT TGG</td>
</tr>
<tr>
<td valign="top" align="left">hPDE4</td>
<td valign="top" align="center">62</td>
<td valign="top" align="left">(F) GTT GAG ACG AAG AAG GTG ACC AG</td>
</tr>
<tr>
<td/>
<td/>
<td valign="top" align="left">(R) GTC GGC CCA TGT TTC CCA CAA TG</td>
</tr>
<tr>
<td valign="top" align="left">hGAPDH</td>
<td valign="top" align="center">52</td>
<td valign="top" align="left">(F) GTC GGA GTC AAC GGA TT</td>
</tr>
<tr>
<td/>
<td/>
<td valign="top" align="left">(R) GCC ATG GGT GGA ATC ATA</td>
</tr>
</tbody>
</table>
</table-wrap></sec>
<sec>
<title>Western blot</title>
<p>SMG cells were isolated and stimulated with the indicated components for 1 h. Cell lysates were prepared in lysis buffer (containing [mM] 20 Tris, 150 NaCl, 2 EDTA, 1% Triton X-100, and a protease inhibitor mixture) and treated as previously described (Lee et al., <xref ref-type="bibr" rid="B17">2016</xref>). Briefly, proteins were denatured via incubation in SDS sample buffer at 37&#x000B0;C for 30 min. The 30 &#x003BC;g of denatured protein samples were subjected to SDS-PAGE and transferred to methanol-soaked polyvinylidene difluoride (PVDF) membranes. Transferred proteins on PVDF membranes were visualized with PDE4 (Fabgennix), &#x003B1;2<sub>A</sub>-adrenergic receptor (Santacruz), IL-6 and caspase-1 (Abcam), and &#x003B2;-actin (Sigma) antibodies by enhanced luminescence solution (Thermo Scientific).</p></sec>
<sec>
<title>Measurement of cAMP concentrations</title>
<p>The cAMP concentration for each sample was determined by cAMP EIA kit (Cayman Chemical Company, Ann Arbor, MI) according to the manufacturer&#x00027;s instructions. Briefly, absorbance wavelength for assay was 405 nm, and cAMP concentration was determined by calculation based on a standard curve. Protein concentrations were measured by Quick Start Bradford Assay (Bio-Rad, Hercules, CA). Each cAMP values were normalized to amount of protein for each samples.</p></sec>
<sec>
<title>Statistical analysis</title>
<p>Results from the indicated number of experiments were expressed as mean &#x000B1; SEM. Differences between means were considered statistically significant when <italic>P</italic> &#x0003C; 0.01 (&#x0002A;) or <italic>P</italic> &#x0003C; 0.05 (&#x00023;).</p></sec></sec>
<sec sec-type="results" id="s3">
<title>Results</title>
<sec>
<title>Effect of Dex on CBE activity in isolated mouse SMG cells and fluid secretion in sealed parotid ducts</title>
<p>Mouse SMG tissue and isolated SMG cells were stained with &#x003B1;2<sub>A</sub>-adrenoceptor antibody (Figures <xref ref-type="fig" rid="F1">1A,B</xref>). Protein expression of &#x003B1;2<sub>A</sub>-adrenoceptor in SMG was evaluated by western blot analysis (Figure <xref ref-type="fig" rid="F1">1C</xref>). We have demonstrated for the first that the &#x003B1;2<sub>A</sub>-adrenoceptor is expressed in the basolateral membrane of SMG cells. Then, to determine the effects of Dex on the modulation of ion transporter activity, we measured CBE activity in parotid, SMG acini, and SMG ductal cells. CBE activity was evaluated by measuring the change in pH<sub>i</sub> induced by acute Cl<sup>&#x02212;</sup> removal and subsequent addition of Cl<sup>&#x02212;</sup> in the presence or absence of Dex. Removal of Cl<sup>&#x02212;</sup> in the perfused solution induced intracellular alkalization. The slope of the change in pH<sub>i</sub> was measured using Cl<sup>&#x02212;</sup>-free <inline-formula><mml:math id="M23"><mml:mrow><mml:msubsup><mml:mrow><mml:mtext>HCO</mml:mtext></mml:mrow><mml:mn>3</mml:mn><mml:mo>-</mml:mo></mml:msubsup></mml:mrow></mml:math></inline-formula>-buffered solution. No changes in CBE activity were found in SMG and parotid acini cells upon Dex treatment (Figures <xref ref-type="fig" rid="F1">1D&#x02013;F</xref>), CBE activity in SMG ductal cells was markedly increased upon acute Dex treatment (Figure <xref ref-type="fig" rid="F1">1E</xref>). Our previous study suggested that CBE is essential for ductal <inline-formula><mml:math id="M24"><mml:mrow><mml:msubsup><mml:mrow><mml:mtext>HCO</mml:mtext></mml:mrow><mml:mn>3</mml:mn><mml:mo>-</mml:mo></mml:msubsup></mml:mrow></mml:math></inline-formula> secretion in the salivary glands (Hong et al., <xref ref-type="bibr" rid="B11">2015</xref>). The clinical side effects of Dex such as hyposecretion raised the question of whether Dex participates in modulation of <inline-formula><mml:math id="M25"><mml:mrow><mml:msubsup><mml:mrow><mml:mtext>HCO</mml:mtext></mml:mrow><mml:mn>3</mml:mn><mml:mo>-</mml:mo></mml:msubsup></mml:mrow></mml:math></inline-formula> transporters. To address this question, we measured ductal fluid secretion using the sealed parotid ductal <italic>ex vivo</italic> system. Interestingly, in contrast to the hyposecretion effect observed clinically (Marks et al., <xref ref-type="bibr" rid="B21">2010</xref>), Dex increased forskolin-stimulated parotid ductal fluid secretion (Figure <xref ref-type="fig" rid="F1">1G</xref>). Dex-stimulated fluid secretion at 40 min was 33.5 &#x000B1; 11.2% higher than in the control (Figure <xref ref-type="fig" rid="F1">1H</xref>). However, long-lasting Dex treatment for 2 h showed no changes in ductal fluid secretion compared to control (data not shown). These data suggest that CBE activity of ductal cells and ductal fluid secretion were activated by acute treatment with Dex.</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption><p><bold>Effect of Dex on CBE activity in isolated mouse SMG cells and fluid secretion in sealed parotid ducts. (A,B)</bold> Localization of &#x003B1;2<sub>A</sub>-adrenergic receptor (AR) in SMG tissue and isolated SMG acini. <bold>(C)</bold> Protein expression &#x003B1;2<sub>A</sub>-AR in SMG. CBE activity was determined by measuring changes in pH<sub>i</sub> in SMG acini <bold>(D)</bold>, SMG ducts <bold>(E)</bold>, and parotid acini <bold>(F)</bold> with and without 100 ng/ml Dex. The slope of pH<sub>i</sub> measured CBE activity in the absence of Cl<sup>&#x02212;</sup> at the beginning of time course (30&#x02013;45 s), and height to reach the point of maximum pH<sub>i</sub> from the minimum point. Bars represent the mean &#x000B1; SEM (<italic>n</italic> &#x0003D; 4, <sup>&#x0002A;</sup><italic>p</italic> &#x0003C; 0.01, &#x00023;<italic>p</italic> &#x0003C; 0.05). <bold>(G)</bold> Sealed parotid ducts were isolated and used to measure fluid secretion in response to stimulation with 5 &#x003BC;M forskolin in the absence (control, open square) and presence of 100 ng/ml Dex (closed rhombus) (<italic>n</italic> &#x0003D; 4, <sup>&#x0002A;</sup><italic>p</italic> &#x0003C; 0.01). <bold>(H)</bold> The mean &#x000B1; SEM at the 40 min secretion time point shows an increase in basal secretion upon Dex treatment.</p></caption>
<graphic xlink:href="fphys-08-00086-g0001.tif"/>
</fig></sec>
<sec>
<title>Effect of Dex on <inline-formula><mml:math id="M26"><mml:mrow><mml:msubsup><mml:mrow><mml:mtext>NH</mml:mtext></mml:mrow><mml:mn>4</mml:mn><mml:mo>+</mml:mo></mml:msubsup></mml:mrow></mml:math></inline-formula> influx in mouse isolated SMG and HSG cells</title>
<p>Fluid secretion is driven by the luminal Cl<sup>&#x02212;</sup> efflux and the basolateral Cl<sup>&#x02212;</sup> influx that occurs across the plasma membrane (Lee et al., <xref ref-type="bibr" rid="B18">2012</xref>). The basolateral Cl<sup>&#x02212;</sup> influx is mediated by NKCC1. We measured <inline-formula><mml:math id="M27"><mml:mrow><mml:msubsup><mml:mrow><mml:mtext>NH</mml:mtext></mml:mrow><mml:mn>4</mml:mn><mml:mo>+</mml:mo></mml:msubsup></mml:mrow></mml:math></inline-formula> influx by measuring the change in pH<sub>i</sub> during 20 mM NH<sub>4</sub>Cl pulse with and without Dex. <inline-formula><mml:math id="M28"><mml:mrow><mml:msubsup><mml:mrow><mml:mtext>NH</mml:mtext></mml:mrow><mml:mn>4</mml:mn><mml:mo>+</mml:mo></mml:msubsup></mml:mrow></mml:math></inline-formula> influx increased in the presence of Dex in isolated SMG acini, however, <inline-formula><mml:math id="M29"><mml:mrow><mml:msubsup><mml:mrow><mml:mtext>NH</mml:mtext></mml:mrow><mml:mn>4</mml:mn><mml:mo>+</mml:mo></mml:msubsup></mml:mrow></mml:math></inline-formula> influx decreased in the presence of the &#x003B1;2-adreneric antagonist 10 &#x003BC;M yohimbine (YOH; Figures <xref ref-type="fig" rid="F2">2A,B</xref>). A longer Dex treatment revealed no effect on <inline-formula><mml:math id="M30"><mml:mrow><mml:msubsup><mml:mrow><mml:mtext>NH</mml:mtext></mml:mrow><mml:mn>4</mml:mn><mml:mo>+</mml:mo></mml:msubsup></mml:mrow></mml:math></inline-formula> influx, whereas, long-lasting YOH treatment (2 h) increased <inline-formula><mml:math id="M31"><mml:mrow><mml:msubsup><mml:mrow><mml:mtext>NH</mml:mtext></mml:mrow><mml:mn>4</mml:mn><mml:mo>+</mml:mo></mml:msubsup></mml:mrow></mml:math></inline-formula> influx (Figure <xref ref-type="fig" rid="F2">2B</xref>). HSG cells were also used to evaluate the long-lasting Dex treatment on <inline-formula><mml:math id="M32"><mml:mrow><mml:msubsup><mml:mrow><mml:mtext>NH</mml:mtext></mml:mrow><mml:mn>4</mml:mn><mml:mo>+</mml:mo></mml:msubsup></mml:mrow></mml:math></inline-formula> influx. <inline-formula><mml:math id="M33"><mml:mrow><mml:msubsup><mml:mrow><mml:mtext>NH</mml:mtext></mml:mrow><mml:mn>4</mml:mn><mml:mo>+</mml:mo></mml:msubsup></mml:mrow></mml:math></inline-formula> influx was increased in HSG cells upon acute Dex treatment, but was partially inhibited with long- lasting Dex treatment for 2 h (Figures <xref ref-type="fig" rid="F2">2C,D</xref>). Part of <inline-formula><mml:math id="M34"><mml:mrow><mml:msubsup><mml:mrow><mml:mtext>NH</mml:mtext></mml:mrow><mml:mn>4</mml:mn><mml:mo>+</mml:mo></mml:msubsup></mml:mrow></mml:math></inline-formula> influx is mediated by NKCC1 (Blanco et al., <xref ref-type="bibr" rid="B3">2013</xref>). Bumetanide (Bumeta) is an inhibitor of NKCC1. The minor effects of NH4<sup>&#x0002B;</sup> entry observed with 10 &#x003BC;M Bumeta (data now shown). The 100 &#x003BC;M Bumeta showed 52% inhibition of NH4<sup>&#x0002B;</sup> entry. Dex treatment partially restored the Bumeta-associated <inline-formula><mml:math id="M35"><mml:mrow><mml:msubsup><mml:mrow><mml:mtext>NH</mml:mtext></mml:mrow><mml:mn>4</mml:mn><mml:mo>+</mml:mo></mml:msubsup></mml:mrow></mml:math></inline-formula> entry (Figure <xref ref-type="fig" rid="F2">2E</xref>). These data suggest that NKCC1-independent <inline-formula><mml:math id="M36"><mml:mrow><mml:msubsup><mml:mrow><mml:mtext>NH</mml:mtext></mml:mrow><mml:mn>4</mml:mn><mml:mo>+</mml:mo></mml:msubsup></mml:mrow></mml:math></inline-formula> influx was activated by acute Dex treatment with Dex, whereas, long-lasting Dex treatment did not inhibit <inline-formula><mml:math id="M37"><mml:mrow><mml:msubsup><mml:mrow><mml:mtext>NH</mml:mtext></mml:mrow><mml:mn>4</mml:mn><mml:mo>+</mml:mo></mml:msubsup></mml:mrow></mml:math></inline-formula> entry.</p>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption><p><bold>Effect of Dex on <inline-formula><mml:math id="M38"><mml:mrow><mml:msubsup><mml:mrow><mml:mtext>NH</mml:mtext></mml:mrow><mml:mn>4</mml:mn><mml:mo>+</mml:mo></mml:msubsup></mml:mrow></mml:math></inline-formula> influx in mouse isolated SMG and HSG cells</bold>. <inline-formula><mml:math id="M39"><mml:mrow><mml:msubsup><mml:mrow><mml:mtext>NH</mml:mtext></mml:mrow><mml:mn>4</mml:mn><mml:mo>+</mml:mo></mml:msubsup></mml:mrow></mml:math></inline-formula> influx was assessed by measuring changes in pH<sub>i</sub> in SMG acini with and without 100 ng/ml Dex. The rate of <inline-formula><mml:math id="M40"><mml:mrow><mml:msubsup><mml:mrow><mml:mtext>NH</mml:mtext></mml:mrow><mml:mn>4</mml:mn><mml:mo>+</mml:mo></mml:msubsup></mml:mrow></mml:math></inline-formula> influx (gray dotted line) was determined from the pH<sub>i</sub> recovery rate in the second phase after 20 mM NH<sub>4</sub>Cl pulse. Bars represent the mean &#x000B1; SEM (<italic>n</italic> &#x0003D; 5). <bold>(A)</bold> Traces of the NH<sub>4</sub>Cl pulses used to measure <inline-formula><mml:math id="M41"><mml:mrow><mml:msubsup><mml:mrow><mml:mtext>NH</mml:mtext></mml:mrow><mml:mn>4</mml:mn><mml:mo>+</mml:mo></mml:msubsup></mml:mrow></mml:math></inline-formula> influx with 100 ng/ml Dex or 10 &#x003BC;M YOH in isolated SMG acini. <bold>(B)</bold> Analysis of <inline-formula><mml:math id="M42"><mml:mrow><mml:msubsup><mml:mrow><mml:mtext>NH</mml:mtext></mml:mrow><mml:mn>4</mml:mn><mml:mo>+</mml:mo></mml:msubsup></mml:mrow></mml:math></inline-formula> influx in isolated SMG acini. Bars represent the mean &#x000B1; SEM (<italic>n</italic> &#x0003D; 4, <sup>&#x0002A;</sup><italic>p</italic> &#x0003C; 0.01). Analysis of <inline-formula><mml:math id="M43"><mml:mrow><mml:msubsup><mml:mrow><mml:mtext>NH</mml:mtext></mml:mrow><mml:mn>4</mml:mn><mml:mo>+</mml:mo></mml:msubsup></mml:mrow></mml:math></inline-formula> influx in HSG cells <bold>(C,D)</bold> and SMG acini <bold>(E)</bold> in the presence of the indicated components including 100 &#x003BC;M Bumetanide (Bumeta). Bars represent the mean &#x000B1; SEM (<italic>n</italic> &#x0003D; 4, <sup>&#x0002A;</sup><italic>p</italic> &#x0003C; 0.01).</p></caption>
<graphic xlink:href="fphys-08-00086-g0002.tif"/>
</fig></sec>
<sec>
<title>Long-lasting Dex treatment on CBE activity in mouse isolated SMG and HSG cells</title>
<p>Although, Dex stimulates CBE activity and <inline-formula><mml:math id="M44"><mml:mrow><mml:msubsup><mml:mrow><mml:mtext>NH</mml:mtext></mml:mrow><mml:mn>4</mml:mn><mml:mo>+</mml:mo></mml:msubsup></mml:mrow></mml:math></inline-formula> entry, it remains unclear how Dex induces fluid hyposecretion. We hypothesized that the Dex effect was time-dependent, thus to evaluate the long-lasting treatment with Dex, we measured CBE activity in cells that were incubated with Dex for 2 h. To avoid isolated SMG cells instability during the prolonged treatment period, we employed a CBE overexpression system that included basolateral anion exchanger 2 (AE2) and luminal solute carrier 26 family SLC26A6 (Figures <xref ref-type="fig" rid="F3">3A,B</xref>). CBE activity in isolated SMG acini and in HSG cells were inhibited by long-lasting Dex treatment (Figures <xref ref-type="fig" rid="F3">3C,D</xref>), suggesting that Dex-induced inhibition of ion transporters plays a role in fluid hyposecretion.</p>
<fig id="F3" position="float">
<label>Figure 3</label>
<caption><p><bold>Long-lasting Dex treatment on CBE activity in in mouse isolated SMG and HSG cells</bold>. SMG and HSG cells were treated with Dex for 2 h. CBE activity was assessed by measuring changes in pH<sub>i</sub> in AE2-transfected cells <bold>(A)</bold>, in SLC26A6-transfected cells <bold>(B)</bold>, in SMG acini <bold>(C)</bold>, and in HSG cells <bold>(D)</bold> with and without 100 ng/ml Dex. Bars show the mean &#x000B1; SEM (<italic>n</italic> &#x0003D; 4, <sup>&#x0002A;</sup><italic>p</italic> &#x0003C; 0.01).</p></caption>
<graphic xlink:href="fphys-08-00086-g0003.tif"/>
</fig></sec>
<sec>
<title>Differential effects of Dex on neurotransmitter inputs and inflammatory mediator-induced intracellular calcium signaling in mouse SMG cells</title>
<p>The fluid secretion function of the salivary glands is regulated by numerous components, including neurotransmitters that modulate spatial and temporal Ca<sup>2&#x0002B;</sup> signaling (Lee et al., <xref ref-type="bibr" rid="B17">2016</xref>). The role of Dex on cholinergic/adrenergic inputs-induced intracellular Ca<sup>2&#x0002B;</sup> concentration ([Ca<sup>2&#x0002B;</sup>]<sub>i</sub>) increases was assessed in SMG cells. Dex did not alter [Ca<sup>2&#x0002B;</sup>]<sub>i</sub> signals in SMG cells (data not shown). SMG cells were stimulated with the &#x003B2;-adrenergic agonist isoproterenol (Iso) and the cholinergic agonist carbamyl choline chloride (CCh) with and without Dex (Figures <xref ref-type="fig" rid="F4">4A,B</xref>). No effect of Dex stimulation was observed in CCh- and Iso-induced [Ca<sup>2&#x0002B;</sup>]<sub>i</sub> signals. To evaluate whether the regulatory effect of Dex in isolated SMG cells is mediated by inflammatory mediators, such as histamine and LPS, histamine-, and LPS-induced [Ca<sup>2&#x0002B;</sup>]<sub>i</sub> measurements were performed with and without Dex. Inflammatory mediators-induced [Ca<sup>2&#x0002B;</sup>]<sub>i</sub> signals were inhibited by Dex (Figures <xref ref-type="fig" rid="F4">4C,D</xref>), thus Dex appears to play a role in inflammatory mediators-induced Ca<sup>2&#x0002B;</sup> signaling.</p>
<fig id="F4" position="float">
<label>Figure 4</label>
<caption><p><bold>Differential effects of Dex on neurotransmitter inputs and inflammatory mediator-induced intracellular calcium signaling in mouse SMG cells. (A)</bold> Changes in [Ca<sup>2&#x0002B;</sup>]<sub>i</sub> induced by 100 &#x003BC;M isoproterenol without (closed circle) and with pre-treatment with 100 ng/ml Dex (open square). All of the traces were averaged. <bold>(B)</bold> Changes in [Ca<sup>2&#x0002B;</sup>]<sub>i</sub> induced by 10 &#x003BC;M carbachol without (closed circle) and with pre-treatment with 100 ng/ml Dex (open square). All of the traces were averaged. <bold>(C)</bold> Changes in [Ca<sup>2&#x0002B;</sup>]<sub>i</sub> induced by 100 nM histamine without (closed circle) and with pre-treatment with 100 ng/ml Dex (closed square). All of the traces were averaged. <bold>(D)</bold> Changes in [Ca<sup>2&#x0002B;</sup>]<sub>i</sub> induced by 20 &#x003BC;g/ml LPS in ducts and in acini without (gray line for ducts and light gray line for acini) and with (black line) pre-treatment with 100 ng/ml Dex. A single trace is shown. Arrows indicate when stimuli were applied to the cells.</p></caption>
<graphic xlink:href="fphys-08-00086-g0004.tif"/>
</fig></sec>
<sec>
<title>Effect of Dex on PDE4 expression</title>
<p>Dex has been linked to post-cAMP activation cellular events in the renal collecting duct (Rouch et al., <xref ref-type="bibr" rid="B30">1997</xref>). PDE4, which consists of four subfamilies, PDE4A-4D, is a well-characterized cAMP-specific enzyme that is expressed in SMG cells (Lee et al., <xref ref-type="bibr" rid="B17">2016</xref>). To determine the effect of Dex on PDE4 expression in SMG cells, we performed semi-qRT-PCR using cells treated with Dex for 2 h. <italic>PDE4D</italic> mRNA expression increased in the presence of Dex (Figures <xref ref-type="fig" rid="F5">5A,B</xref>). Dex-induced time-dependent increase in <italic>PDE4</italic> mRNA expression was also seen in HSG cells (Figures <xref ref-type="fig" rid="F5">5C,D</xref>). We confirmed this Dex-induced stimulatory effect by immunostaining isolated SMG cells with PDE4 antibody (Figures <xref ref-type="fig" rid="F6">6A,C</xref>). As a specificity control, expression of the tight junction marker ZO-1 did not change in the presence of Dex (Figures <xref ref-type="fig" rid="F6">6B,C</xref>). We also found that PDE4 was dominantly expressed in the luminal membrane of SMG cells and that increased PDE4 expression was observed in Dex-treated SMG cells. We confirmed the increase in PDE4 protein expression in the presence of Dex for 2 h by an enhancement in the 65-kDa band that corresponds to PDE4 (Figure <xref ref-type="fig" rid="F6">6D</xref>).</p>
<fig id="F5" position="float">
<label>Figure 5</label>
<caption><p><bold>Effect of Dex on PDE4 mRNA expression. (A)</bold> The mRNA expression of <italic>PDE4A&#x02013;D</italic> subfamily members with and without 100 ng/ml Dex in SMG cells. <bold>(B)</bold> Results are expressed as fold expression relative to the control and mean &#x000B1; SEM (<italic>n</italic> &#x0003D; 3, <sup>&#x0002A;</sup><italic>p</italic> &#x0003C; 0.01). <bold>(C,D)</bold> Time-dependent <italic>PDE4</italic> mRNA expression with and without 100 ng/ml Dex in HSG cells (<italic>n</italic> &#x0003D; 3, &#x00023;<italic>p</italic> &#x0003C; 0.05).</p></caption>
<graphic xlink:href="fphys-08-00086-g0005.tif"/>
</fig>
<fig id="F6" position="float">
<label>Figure 6</label>
<caption><p><bold>Effect of Dex on PDE4 expression. (A,B)</bold> Immunofluorescence staining of PDE4 (red) and ZO-1 (green) in isolated SMG cells. <bold>(C)</bold> Relative intensities of PDE4 and ZO-1 staining divided by area. Bars represent the mean &#x000B1; SEM (<italic>n</italic> &#x0003D; 3, <sup>&#x0002A;</sup><italic>p</italic> &#x0003C; 0.01). NC, negative control. <bold>(D)</bold> PDE4 and &#x003B2;-actin protein expressions with and without 100 ng/ml Dex in SMG cells.</p></caption>
<graphic xlink:href="fphys-08-00086-g0006.tif"/>
</fig></sec>
<sec>
<title>Dex-induced inhibition of LPS-induced inflammatory cytokine expression and cAMP concentration</title>
<p>To evaluate the anti-inflammatory role of Dex on SMG cells, cells were stimulated with LPS from <italic>P. gingivalis</italic>, and IL-6 expression was measured. Previously, we found that SMG cells express TLR4, which is involved in LPS signaling (Lee et al., <xref ref-type="bibr" rid="B17">2016</xref>). Dex inhibited LPS-induced <italic>IL-6</italic> mRNA expression (&#x00023;<italic>p</italic> &#x0003C; 0.05), however, cytosolic and secreted IL-6 protein levels showed no statistical difference (<italic>p</italic> &#x0003C; 0.1; Figures <xref ref-type="fig" rid="F7">7A,B</xref>).</p>
<fig id="F7" position="float">
<label>Figure 7</label>
<caption><p><bold>Dex-induced inhibition of LPS-induced inflammatory cytokine expression and cAMP concentration</bold>. <bold>(A)</bold> SMG cells were stimulated with LPS, treated with 100 ng/ml Dex, and then IL-6 mRNA and protein expression were measured in cell lysates (Lys) and cell supernatants (Sup). <bold>(B)</bold> Bars represent the mean &#x000B1; SEM (<italic>n</italic> &#x0003D; 4, &#x00023;<italic>p</italic> &#x0003C; 0.05). <bold>(C)</bold> LPS-induced <italic>Nox2</italic> and <italic>Nox4</italic> mRNA expression in the presence of 100 ng/ml Dex. <bold>(D)</bold> Analysis of <italic>Nox2</italic> and <italic>Nox4</italic> mRNA expression in the presence of the indicated components (<italic>n</italic> &#x0003D; 5, <sup>&#x0002A;</sup><italic>p</italic> &#x0003C; 0.01). <bold>(E)</bold> PDE4 protein expression in LPS-stimulated SMG cells. The arrowheads indicate PDE4A and PDE4D bands at 65 and 102 kDa, respectively. <bold>(F)</bold> Analysis of PDE4 expression. Bars show the mean &#x000B1; SEM (<italic>n</italic> &#x0003D; 4). <bold>(G)</bold> cAMP ratios in Dex-treated whole SMG cells (<italic>n</italic> &#x0003D; 4, <sup>&#x0002A;</sup><italic>p</italic> &#x0003C; 0.01).</p></caption>
<graphic xlink:href="fphys-08-00086-g0007.tif"/>
</fig>
<p>NADPH oxidases (Nox) are a major source of reactive oxygen species (ROS; Vieceli Dalla Sega et al., <xref ref-type="bibr" rid="B38">2014</xref>), and LPS-induced oxidative stress was found to increase production of ROS through Nox4 (Ngkelo et al., <xref ref-type="bibr" rid="B23">2012</xref>). Normal salivary glands cells express Nox2 and Nox4 (Tateishi et al., <xref ref-type="bibr" rid="B37">2008</xref>). We confirmed that SMG cells expressed <italic>Nox2</italic> and <italic>Nox4</italic> mRNA and that Dex attenuated <italic>Nox4</italic>, but not <italic>Nox2</italic> mRNA expression in SMG cells (Figures <xref ref-type="fig" rid="F7">7C,D</xref>). To further examine the anti-inflammatory role of Dex, cells were stimulated with LPS and exposed to Dex. The presence of enhanced bands at 65 and 102 kDa, which correspond to PDE4A and PDE4D, respectively, in a Western blot revealed increased PDE4 expression in LPS-stimulated cells in the presence of Dex (Figures <xref ref-type="fig" rid="F7">7E,F</xref>). We obtained the enhanced bands at 65 and 102 kDa, respectively in the presence of Dex. To confirm the effects of Dex on cAMP concentration, isolated SMG cells were treated with Dex for various times (Figure <xref ref-type="fig" rid="F7">7G</xref>). The activation of &#x003B1;2 adrenoceptors activates G<sub>i</sub> protein, which inhibits adenylate cyclase. Therefore, the activation of &#x003B1;2 adrenoceptors results in lower cAMP levels. Analysis of cAMP concentration relative to time of Dex treatment indicated that 2 h of Dex treatment reduced cAMP levels in isolated SMG cells.</p></sec></sec>
<sec sec-type="discussion" id="s4">
<title>Discussion</title>
<p>The major novel finding of the present study was that &#x003B1;2-adrenoceptors are expressed in the basolateral membrane of mouse SMG cells and that the selective &#x003B1;2-adrenoceptor agonist Dex acutely increased ductal CBE activity and NKCC1-independent <inline-formula><mml:math id="M45"><mml:mrow><mml:msubsup><mml:mrow><mml:mtext>NH</mml:mtext></mml:mrow><mml:mn>4</mml:mn><mml:mo>+</mml:mo></mml:msubsup></mml:mrow></mml:math></inline-formula> entry, as well as increased fluid secretion in primary isolated SMG acini and ductal cells. Long-lasting treatment (2 h) with Dex inhibited CBE activity but not <inline-formula><mml:math id="M46"><mml:mrow><mml:msubsup><mml:mrow><mml:mtext>NH</mml:mtext></mml:mrow><mml:mn>4</mml:mn><mml:mo>+</mml:mo></mml:msubsup></mml:mrow></mml:math></inline-formula> entry. Reduced function of transporters caused by the increased expression of PDE4, which may be involved in reduced cAMP level in SMG. Recent evidence indicated that the &#x003B1;2-adrenoceptor agonist Dex has anti-inflammatory properties in various tissues (Peng et al., <xref ref-type="bibr" rid="B27">2013</xref>; Tanabe et al., <xref ref-type="bibr" rid="B35">2014</xref>; Yang and Hong, <xref ref-type="bibr" rid="B40">2015</xref>). In this study, we also demonstrated an anti-inflammatory role for Dex in which Dex inhibits IL-6 mRNA and protein expression and <italic>Nox4</italic> mRNA expression in LPS-stimulated SMG cells.</p>
<p>A previous study demonstrated that the administration of Dex induced low systolic and diastolic blood pressure even though an initial blood pressure increase was observed (Karhuvaara et al., <xref ref-type="bibr" rid="B14">1991</xref>). Previously, we found that the PDE4 inhibitor rolipram regulates intracellular cAMP levels and inhibits inflammatory signaling in the salivary glands and that apical localization of PDE4 may be involved in the activation of cAMP-dependent secretion (Lee et al., <xref ref-type="bibr" rid="B17">2016</xref>). Inhibition of PDE prevents cAMP breakdown, increases intracellular cAMP concentrations, and may lead to cardiac stimulation. However, Dex-mediated PDE-sensitivity, as well as the differential roles and expression patterns of each PDE subfamily member should be further investigated in cardiac tissue and in the salivary glands.</p>
<p><inline-formula><mml:math id="M47"><mml:mrow><mml:msubsup><mml:mrow><mml:mtext>HCO</mml:mtext></mml:mrow><mml:mn>3</mml:mn><mml:mo>-</mml:mo></mml:msubsup></mml:mrow></mml:math></inline-formula> transporters, including AE2 and SLC26A6, have been shown to be required for cAMP-stimulated anion secretion (Gawenis et al., <xref ref-type="bibr" rid="B10">2010</xref>; Ahuja et al., <xref ref-type="bibr" rid="B1">2014</xref>). Apical cAMP-associated ion transporters localize to the PDE4-rich environment following long Dex treatment, and this may induce impaired saliva secretion. In the salivary glands, PDE activity varies depending on intracellular cAMP concentrations due to salivary stimulation during the tissue development (Tanaka et al., <xref ref-type="bibr" rid="B36">2002</xref>). Although, the cellular distributions and expression levels of PDE family members in the salivary glands remain to be elucidated, the long Dex-induced increase in PDE4D expression led to a reduction in the function of the cAMP-dependent transporters NKCC in acini and the Cl<sup>&#x02212;</sup>/<inline-formula><mml:math id="M48"><mml:mrow><mml:msubsup><mml:mrow><mml:mtext>HCO</mml:mtext></mml:mrow><mml:mn>3</mml:mn><mml:mo>-</mml:mo></mml:msubsup></mml:mrow></mml:math></inline-formula> exchanger in ductal cells. To our knowledge, this is the first demonstration of long-lasting treatment with Dex-induced modulation of PDE4 expression. It will be of particular interest to determine whether acute stimulation of Dex requires signaling molecule to activate transporters including AE2 and SLC26A6, activates other Cl<sup>&#x02212;</sup> transporters (e.g., cystic fibrosis transmembrane conductance regulator), or activates directly (Figure <xref ref-type="fig" rid="F8">8</xref>). The prediction of this model is that Dex may possess the dominant effect on Cl<sup>&#x02212;</sup> movement.</p>
<fig id="F8" position="float">
<label>Figure 8</label>
<caption><p><bold>Schematic model of Dex-modulated signaling</bold>. Dex, dexmedetomidine; &#x003B1;2<sub>A</sub>-AR, &#x003B1;2<sub>A</sub>-adrenoceptor; NKCC1, Na<sup>&#x0002B;</sup>-K<sup>&#x0002B;</sup>-2Cl<sup>&#x02212;</sup> cotransporter1; AE2, anion exchanger2; SLC26A6, solute carrier 26 family A6; Nox4, NADPH oxidase 4; LPS, lipopolysaccharide; TLR4, toll-like receptor 4; PDE, phosphodiesterase; YOH, yohimbine. Acute (black) and long-lasting (red) treatment with Dex.</p></caption>
<graphic xlink:href="fphys-08-00086-g0008.tif"/>
</fig>
<p>PDE4 functionally associates with the &#x003B1;2-adrenoceptor by modulating intracellular levels of cAMP in noradrenergic neurons (Robichaud et al., <xref ref-type="bibr" rid="B29">2002</xref>). In this study, we provided direct evidence that Dex modulates PDE4D expression. PDE4 activation has been found to be involved in a broad spectrum of cellular events, for example, depletion of Nox4 decreases the cAMP concentration and aquaporin 2 (AQP2) expression in a PDE4-dependent manner in renal collecting duct principal cells (F&#x000E9;raille et al., <xref ref-type="bibr" rid="B9">2014</xref>). As shown in Figure <xref ref-type="fig" rid="F7">7C</xref>, administration of Dex also inhibits Nox4 expression in SMG cells. As numerous physiological roles have been attributed to Nox4 in various tissues, a Nox4 deficiency as a result of long-lasting treatment with Dex could associate with kidney and salivary glands function, including AQP expression. PDE4 activation also attenuates cardiomyocyte hypertrophy by inhibiting nuclear PKA activity (Fan Chung, <xref ref-type="bibr" rid="B8">2006</xref>).</p>
<p>The side effects of PDE4 inhibitors have been linked to PDE4-related emesis (Robichaud et al., <xref ref-type="bibr" rid="B29">2002</xref>). Although, it has been difficult to define the role of PDE4 in emesis, activation of the &#x003B1;2-adrenoceptor by Dex leads to enhanced expression of PDE4D in the salivary glands.</p>
<p>This study suggests that activation of the &#x003B1;2-adrenoceptor and Dex-mediated regulation of PDE4D play roles in salivary signaling. Moreover, the cAMP/PDE4D axis is associated with the microenvironment of the transporters in the salivary glands. Thus, clearer understanding of PDE4-dependent/independent cellular signaling in the salivary glands could prevent side effects, such as fluid hyposecretion after operations and could prevent choking on saliva during anesthesia.</p></sec>
<sec id="s5">
<title>Author contributions</title>
<p>For correspondence, KS and JH contributed equally to this work. JH, JL, and MJ performed and interpreted experiments; KP, CP, and KS conceived and directed the studies; and JH wrote the manuscript with contribution by all authors.</p>
<sec>
<title>Conflict of interest statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec>
</sec>
</body>
<back>
<ack><p>This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT &#x00026; Future Planning (2014R1A1A3049477), and a grant of the Korea Health Technology R&#x00026;D Project through the Korea Health Industry Development Institute (KHIDI) funded by the Ministry of Health &#x00026; Welfare, Republic of Korea (HI13C-1602-010015).</p>
</ack>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ahuja</surname> <given-names>M.</given-names></name> <name><surname>Jha</surname> <given-names>A.</given-names></name> <name><surname>Maleth</surname> <given-names>J.</given-names></name> <name><surname>Park</surname> <given-names>S.</given-names></name> <name><surname>Muallem</surname> <given-names>S.</given-names></name></person-group> (<year>2014</year>). <article-title>cAMP and Ca<sup>2&#x0002B;</sup> signaling in secretory epithelia: crosstalk and synergism</article-title>. <source>Cell Calcium</source> <volume>55</volume>, <fpage>385</fpage>&#x02013;<lpage>393</lpage>. <pub-id pub-id-type="doi">10.1016/j.ceca.2014.01.006</pub-id><pub-id pub-id-type="pmid">24613710</pub-id></citation>
</ref>
<ref id="B2">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bischoff</surname> <given-names>P.</given-names></name> <name><surname>Kochs</surname> <given-names>E.</given-names></name></person-group> (<year>1993</year>). <article-title>[Alpha 2-agonists in anesthesia and intensive medicine]</article-title>. <source>Anasthesiol. Intensivmed. Notfallmed. Schmerzther.</source> <volume>28</volume>, <fpage>2</fpage>&#x02013;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1055/s-2007-998867</pub-id><pub-id pub-id-type="pmid">8096770</pub-id></citation>
</ref>
<ref id="B3">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Blanco</surname> <given-names>V. M.</given-names></name> <name><surname>M&#x000E1;rquez</surname> <given-names>M. S.</given-names></name> <name><surname>Alvarez-Leefmans</surname> <given-names>F. J.</given-names></name></person-group> (<year>2013</year>). <article-title>Parallel changes in intracellular water volume and pH induced by NH<sub>3</sub>/NH<sub>4&#x0002B;</sub> exposure in single neuroblastoma cells</article-title>. <source>Cell. Physiol. Biochem.</source> <volume>32</volume>, <fpage>57</fpage>&#x02013;<lpage>76</lpage>. <pub-id pub-id-type="doi">10.1159/000356624</pub-id><pub-id pub-id-type="pmid">24429815</pub-id></citation>
</ref>
<ref id="B4">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dauphinee</surname> <given-names>S. M.</given-names></name> <name><surname>Karsan</surname> <given-names>A.</given-names></name></person-group> (<year>2006</year>). <article-title>Lipopolysaccharide signaling in endothelial cells</article-title>. <source>Lab. Invest.</source> <volume>86</volume>, <fpage>9</fpage>&#x02013;<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1038/labinvest.3700366</pub-id><pub-id pub-id-type="pmid">16357866</pub-id></citation>
</ref>
<ref id="B5">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Engelhard</surname> <given-names>K.</given-names></name> <name><surname>Werner</surname> <given-names>C.</given-names></name> <name><surname>Kaspar</surname> <given-names>S.</given-names></name> <name><surname>M&#x000F6;llenberg</surname> <given-names>O.</given-names></name> <name><surname>Blobner</surname> <given-names>M.</given-names></name> <name><surname>Bachl</surname> <given-names>M.</given-names></name> <etal/></person-group>. (<year>2002</year>). <article-title>Effect of the &#x003B1;2-agonist dexmedetomidine on cerebral neurotransmitter concentrations during cerebral ischemia in rats</article-title>. <source>Anesthesiology</source> <volume>96</volume>, <fpage>450</fpage>&#x02013;<lpage>457</lpage>. <pub-id pub-id-type="doi">10.1097/00000542-200202000-00034</pub-id><pub-id pub-id-type="pmid">11818781</pub-id></citation>
</ref>
<ref id="B6">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ersson</surname> <given-names>C.</given-names></name> <name><surname>Thorman</surname> <given-names>R.</given-names></name> <name><surname>Rodhe</surname> <given-names>Y.</given-names></name> <name><surname>M&#x000F6;ller</surname> <given-names>L.</given-names></name> <name><surname>Hylander</surname> <given-names>B.</given-names></name></person-group> (<year>2011</year>). <article-title>DNA damage in salivary gland tissue in patients with chronic kidney disease, measured by the comet assay</article-title>. <source>Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod.</source> <volume>112</volume>, <fpage>209</fpage>&#x02013;<lpage>215</lpage>. <pub-id pub-id-type="doi">10.1016/j.tripleo.2011.03.016</pub-id><pub-id pub-id-type="pmid">21684780</pub-id></citation>
</ref>
<ref id="B7">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Evans</surname> <given-names>R. L.</given-names></name> <name><surname>Turner</surname> <given-names>R. J.</given-names></name></person-group> (<year>1997</year>). <article-title>Upregulation of Na<sup>&#x0002B;</sup>-K<sup>&#x0002B;</sup>&#x02212;2Cl<sup>&#x02212;</sup> cotransporter activity in rat parotid acinar cells by muscarinic stimulation</article-title>. <source>J. Physiol.</source> <volume>499</volume>(<issue>Pt 2</issue>), <fpage>351</fpage>&#x02013;<lpage>359</lpage>. <pub-id pub-id-type="doi">10.1113/jphysiol.1997.sp021932</pub-id><pub-id pub-id-type="pmid">9080365</pub-id></citation>
</ref>
<ref id="B8">
<citation citation-type="thesis"><person-group person-group-type="author"><name><surname>Fan Chung</surname> <given-names>K.</given-names></name></person-group> (<year>2006</year>). <article-title>Phosphodiesterase inhibitors in airways disease</article-title>. <source>Eur. J. Pharmacol.</source> <volume>533</volume>, <fpage>110</fpage>&#x02013;<lpage>117</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejphar.2005.12.059</pub-id><pub-id pub-id-type="pmid">16458289</pub-id></citation>
</ref>
<ref id="B9">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>F&#x000E9;raille</surname> <given-names>E.</given-names></name> <name><surname>Dizin</surname> <given-names>E.</given-names></name> <name><surname>Roth</surname> <given-names>I.</given-names></name> <name><surname>Derouette</surname> <given-names>J. P.</given-names></name> <name><surname>Szanto</surname> <given-names>I.</given-names></name> <name><surname>Martin</surname> <given-names>P. Y.</given-names></name> <etal/></person-group>. (<year>2014</year>). <article-title>NADPH oxidase 4 deficiency reduces aquaporin-2 mRNA expression in cultured renal collecting duct principal cells via increased PDE3 and PDE4 activity</article-title>. <source>PLoS ONE</source> <volume>9</volume>:<fpage>e87239</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0087239</pub-id><pub-id pub-id-type="pmid">24466344</pub-id></citation>
</ref>
<ref id="B10">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gawenis</surname> <given-names>L. R.</given-names></name> <name><surname>Bradford</surname> <given-names>E. M.</given-names></name> <name><surname>Alper</surname> <given-names>S. L.</given-names></name> <name><surname>Prasad</surname> <given-names>V.</given-names></name> <name><surname>Shull</surname> <given-names>G. E.</given-names></name></person-group> (<year>2010</year>). <article-title>AE2 Cl<sup>&#x02212;</sup>/HCO3<sup>&#x02212;</sup> exchanger is required for normal cAMP-stimulated anion secretion in murine proximal colon</article-title>. <source>Am. J. Physiol. Gastrointest. Liver Physiol.</source> <volume>298</volume>, <fpage>G493</fpage>&#x02013;<lpage>G503</lpage>. <pub-id pub-id-type="doi">10.1152/ajpgi.00178.2009</pub-id><pub-id pub-id-type="pmid">20110461</pub-id></citation>
</ref>
<ref id="B11">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hong</surname> <given-names>J. H.</given-names></name> <name><surname>Muhammad</surname> <given-names>E.</given-names></name> <name><surname>Zheng</surname> <given-names>C.</given-names></name> <name><surname>Hershkovitz</surname> <given-names>E.</given-names></name> <name><surname>Alkrinawi</surname> <given-names>S.</given-names></name> <name><surname>Loewenthal</surname> <given-names>N.</given-names></name> <etal/></person-group>. (<year>2015</year>). <article-title>Essential role of carbonic anhydrase XII in secretory gland fluid and HCO3 <sup>&#x02212;</sup> secretion revealed by disease causing human mutation</article-title>. <source>J. Physiol. (Lond).</source> <volume>593</volume>, <fpage>5299</fpage>&#x02013;<lpage>5312</lpage>. <pub-id pub-id-type="doi">10.1113/JP271378</pub-id><pub-id pub-id-type="pmid">26486891</pub-id></citation>
</ref>
<ref id="B12">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hong</surname> <given-names>J. H.</given-names></name> <name><surname>Park</surname> <given-names>S.</given-names></name> <name><surname>Shcheynikov</surname> <given-names>N.</given-names></name> <name><surname>Muallem</surname> <given-names>S.</given-names></name></person-group> (<year>2014</year>). <article-title>Mechanism and synergism in epithelial fluid and electrolyte secretion</article-title>. <source>Pflugers Arch.</source> <volume>466</volume>, <fpage>1487</fpage>&#x02013;<lpage>1499</lpage>. <pub-id pub-id-type="doi">10.1007/s00424-013-1390-1</pub-id><pub-id pub-id-type="pmid">24240699</pub-id></citation>
</ref>
<ref id="B13">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jeong</surname> <given-names>Y. S.</given-names></name> <name><surname>Hong</surname> <given-names>J. H.</given-names></name></person-group> (<year>2016</year>). <article-title>Governing effect of regulatory proteins for Cl<sup>&#x02212;</sup>/HCO<sup>3&#x02212;</sup> exchanger 2 activity</article-title>. <source>Channels (Austin)</source> <volume>10</volume>, <fpage>214</fpage>&#x02013;<lpage>224</lpage>. <pub-id pub-id-type="doi">10.1080/19336950.2015.1134068</pub-id><pub-id pub-id-type="pmid">26716707</pub-id></citation>
</ref>
<ref id="B14">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Karhuvaara</surname> <given-names>S.</given-names></name> <name><surname>Kallio</surname> <given-names>A.</given-names></name> <name><surname>Salonen</surname> <given-names>M.</given-names></name> <name><surname>Tuominen</surname> <given-names>J.</given-names></name> <name><surname>Scheinin</surname> <given-names>M.</given-names></name></person-group> (<year>1991</year>). <article-title>Rapid reversal of alpha 2-adrenoceptor agonist effects by atipamezole in human volunteers</article-title>. <source>Br. J. Clin. Pharmacol.</source> <volume>31</volume>, <fpage>160</fpage>&#x02013;<lpage>165</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2125.1991.tb05505.x</pub-id><pub-id pub-id-type="pmid">1675577</pub-id></citation>
</ref>
<ref id="B15">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kili&#x000E7;</surname> <given-names>K.</given-names></name> <name><surname>Hanci</surname> <given-names>V.</given-names></name> <name><surname>Selek</surname> <given-names>S.</given-names></name> <name><surname>S&#x000F6;zmen</surname> <given-names>M.</given-names></name> <name><surname>Kilic</surname> <given-names>N.</given-names></name> <name><surname>Citil</surname> <given-names>M.</given-names></name> <etal/></person-group>. (<year>2012</year>). <article-title>The effects of dexmedetomidine on mesenteric arterial occlusion-associated gut ischemia and reperfusion-induced gut and kidney injury in rabbits</article-title>. <source>J. Surg. Res.</source> <volume>178</volume>, <fpage>223</fpage>&#x02013;<lpage>232</lpage>. <pub-id pub-id-type="doi">10.1016/j.jss.2012.03.073</pub-id><pub-id pub-id-type="pmid">22560540</pub-id></citation>
</ref>
<ref id="B16">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kocoglu</surname> <given-names>H.</given-names></name> <name><surname>Karaaslan</surname> <given-names>K.</given-names></name> <name><surname>Gonca</surname> <given-names>E.</given-names></name> <name><surname>Bozdogan</surname> <given-names>O.</given-names></name> <name><surname>Gulcu</surname> <given-names>N.</given-names></name></person-group> (<year>2008</year>). <article-title>Preconditionin effects of dexmedetomidine on myocardial ischemia/reperfusion injury in rats</article-title>. <source>Curr. Ther. Res. Clin. Exp.</source> <volume>69</volume>, <fpage>150</fpage>&#x02013;<lpage>158</lpage>. <pub-id pub-id-type="doi">10.1016/j.curtheres.2008.04.003</pub-id><pub-id pub-id-type="pmid">24692794</pub-id></citation>
</ref>
<ref id="B17">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>D. U.</given-names></name> <name><surname>Shin</surname> <given-names>D. M.</given-names></name> <name><surname>Hong</surname> <given-names>J. H.</given-names></name></person-group> (<year>2016</year>). <article-title>The regulatory role of rolipram on inflammatory mediators and cholinergic/adrenergic stimulation-induced signals in isolated primary mouse submandibular gland cells</article-title>. <source>Mediators Inflamm.</source> <volume>2016</volume>:<fpage>3745961</fpage>. <pub-id pub-id-type="doi">10.1155/2016/3745961</pub-id><pub-id pub-id-type="pmid">27143817</pub-id></citation>
</ref>
<ref id="B18">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>M. G.</given-names></name> <name><surname>Ohana</surname> <given-names>E.</given-names></name> <name><surname>Park</surname> <given-names>H. W.</given-names></name> <name><surname>Yang</surname> <given-names>D.</given-names></name> <name><surname>Muallem</surname> <given-names>S.</given-names></name></person-group> (<year>2012</year>). <article-title>Molecular mechanism of pancreatic and salivary gland fluid and HCO3 secretion</article-title>. <source>Physiol. Rev.</source> <volume>92</volume>, <fpage>39</fpage>&#x02013;<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1152/physrev.00011.2011</pub-id><pub-id pub-id-type="pmid">22298651</pub-id></citation>
</ref>
<ref id="B19">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>G.</given-names></name> <name><surname>Song</surname> <given-names>H.</given-names></name> <name><surname>Qiu</surname> <given-names>L.</given-names></name> <name><surname>He</surname> <given-names>A.</given-names></name> <name><surname>Tong</surname> <given-names>F.</given-names></name> <name><surname>Wan</surname> <given-names>Q.</given-names></name> <etal/></person-group>. (<year>2016</year>). <article-title>Dexmedetomidine preconditioning inhibits the long term inflammation induced by renal ischemia/reperfusion injury in rats</article-title>. <source>Acta Cir. Bras.</source> <volume>31</volume>, <fpage>8</fpage>&#x02013;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1590/S0102-865020160010000002</pub-id><pub-id pub-id-type="pmid">26840350</pub-id></citation>
</ref>
<ref id="B20">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>X.</given-names></name> <name><surname>Pei</surname> <given-names>C.</given-names></name> <name><surname>Yan</surname> <given-names>S.</given-names></name> <name><surname>Liu</surname> <given-names>G.</given-names></name> <name><surname>Liu</surname> <given-names>G.</given-names></name> <name><surname>Chen</surname> <given-names>W.</given-names></name> <etal/></person-group>. (<year>2015</year>). <article-title>NADPH oxidase 1-dependent ROS is crucial for TLR4 signaling to promote tumor metastasis of non-small cell lung cancer</article-title>. <source>Tumour Biol.</source> <volume>36</volume>, <fpage>1493</fpage>&#x02013;<lpage>1502</lpage>. <pub-id pub-id-type="doi">10.1007/s13277-014-2639-9</pub-id><pub-id pub-id-type="pmid">25592377</pub-id></citation>
</ref>
<ref id="B21">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Marks</surname> <given-names>R.</given-names></name> <name><surname>Tanner</surname> <given-names>L.</given-names></name> <name><surname>Wenleder</surname> <given-names>B.</given-names></name></person-group> (<year>2010</year>). <article-title>Management of a tumor in the distal trachea while maintaining spontaneous ventilation</article-title>. <source>J. Anesth.</source> <volume>24</volume>, <fpage>932</fpage>&#x02013;<lpage>934</lpage>. <pub-id pub-id-type="doi">10.1007/s00540-010-1011-5</pub-id><pub-id pub-id-type="pmid">20799045</pub-id></citation>
</ref>
<ref id="B22">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Moreira</surname> <given-names>T. S.</given-names></name> <name><surname>Takakura</surname> <given-names>A. C.</given-names></name> <name><surname>Menani</surname> <given-names>J. V.</given-names></name> <name><surname>Colombari</surname> <given-names>E.</given-names></name></person-group> (<year>2013</year>). <article-title>Activation of central &#x003B1;2-adrenoceptors mediates salivary gland vasoconstriction</article-title>. <source>Arch. Oral Biol.</source> <volume>58</volume>, <fpage>167</fpage>&#x02013;<lpage>173</lpage>. <pub-id pub-id-type="doi">10.1016/j.archoralbio.2012.06.017</pub-id><pub-id pub-id-type="pmid">22818538</pub-id></citation>
</ref>
<ref id="B23">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ngkelo</surname> <given-names>A.</given-names></name> <name><surname>Meja</surname> <given-names>K.</given-names></name> <name><surname>Yeadon</surname> <given-names>M.</given-names></name> <name><surname>Adcock</surname> <given-names>I.</given-names></name> <name><surname>Kirkham</surname> <given-names>P. A.</given-names></name></person-group> (<year>2012</year>). <article-title>LPS induced inflammatory responses in human peripheral blood mononuclear cells is mediated through NOX4 and Gialpha dependent PI-3kinase signalling</article-title>. <source>J. Inflamm. (Lond).</source> <volume>9</volume>:<fpage>1</fpage>. <pub-id pub-id-type="doi">10.1186/1476-9255-9-1</pub-id><pub-id pub-id-type="pmid">22239975</pub-id></citation>
</ref>
<ref id="B24">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Okada</surname> <given-names>H.</given-names></name> <name><surname>Kurita</surname> <given-names>T.</given-names></name> <name><surname>Mochizuki</surname> <given-names>T.</given-names></name> <name><surname>Morita</surname> <given-names>K.</given-names></name> <name><surname>Sato</surname> <given-names>S.</given-names></name></person-group> (<year>2007</year>). <article-title>The cardioprotective effect of dexmedetomidine on global ischaemia in isolated rat hearts</article-title>. <source>Resuscitation</source> <volume>74</volume>, <fpage>538</fpage>&#x02013;<lpage>545</lpage>. <pub-id pub-id-type="doi">10.1016/j.resuscitation.2007.01.032</pub-id><pub-id pub-id-type="pmid">17391832</pub-id></citation>
</ref>
<ref id="B25">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Omori</surname> <given-names>K.</given-names></name> <name><surname>Kotera</surname> <given-names>J.</given-names></name></person-group> (<year>2007</year>). <article-title>Overview of PDEs and their regulation</article-title>. <source>Circ. Res.</source> <volume>100</volume>, <fpage>309</fpage>&#x02013;<lpage>327</lpage>. <pub-id pub-id-type="doi">10.1161/01.RES.0000256354.95791.f1</pub-id><pub-id pub-id-type="pmid">17307970</pub-id></citation>
</ref>
<ref id="B26">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Park</surname> <given-names>S.</given-names></name> <name><surname>Shcheynikov</surname> <given-names>N.</given-names></name> <name><surname>Hong</surname> <given-names>J. H.</given-names></name> <name><surname>Zheng</surname> <given-names>C.</given-names></name> <name><surname>Suh</surname> <given-names>S. H.</given-names></name> <name><surname>Kawaai</surname> <given-names>K.</given-names></name> <etal/></person-group>. (<year>2013</year>). <article-title>Irbit mediates synergy between ca<sup>2&#x0002B;</sup> and cAMP signaling pathways during epithelial transport in mice</article-title>. <source>Gastroenterology</source> <volume>145</volume>, <fpage>232</fpage>&#x02013;<lpage>241</lpage>. <pub-id pub-id-type="doi">10.1053/j.gastro.2013.03.047</pub-id><pub-id pub-id-type="pmid">23542070</pub-id></citation>
</ref>
<ref id="B27">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname> <given-names>M.</given-names></name> <name><surname>Wang</surname> <given-names>Y. L.</given-names></name> <name><surname>Wang</surname> <given-names>C. Y.</given-names></name> <name><surname>Chen</surname> <given-names>C.</given-names></name></person-group> (<year>2013</year>). <article-title>Dexmedetomidine attenuates lipopolysaccharide-induced proinflammatory response in primary microglia</article-title>. <source>J. Surg. Res.</source> <volume>179</volume>, <fpage>e219</fpage>&#x02013;<lpage>225</lpage>. <pub-id pub-id-type="doi">10.1016/j.jss.2012.05.047</pub-id><pub-id pub-id-type="pmid">22683080</pub-id></citation>
</ref>
<ref id="B28">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rabin</surname> <given-names>B. C.</given-names></name> <name><surname>Guo</surname> <given-names>T. Z.</given-names></name> <name><surname>Maze</surname> <given-names>M.</given-names></name></person-group> (<year>1997</year>). <article-title>Dissociation of hypnotic-anesthetic actions of &#x003B1;<sub>2</sub> agonists from cyclic AMP in the rat</article-title>. <source>Pharmacol. Biochem. Behav.</source> <volume>57</volume>, <fpage>23</fpage>&#x02013;<lpage>29</lpage>. <pub-id pub-id-type="doi">10.1016/S0091-3057(96)00118-9</pub-id><pub-id pub-id-type="pmid">9164550</pub-id></citation>
</ref>
<ref id="B29">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Robichaud</surname> <given-names>A.</given-names></name> <name><surname>Savoie</surname> <given-names>C.</given-names></name> <name><surname>Stamatiou</surname> <given-names>P. B.</given-names></name> <name><surname>Lachance</surname> <given-names>N.</given-names></name> <name><surname>Jolicoeur</surname> <given-names>P.</given-names></name> <name><surname>Rasori</surname> <given-names>R.</given-names></name> <etal/></person-group>. (<year>2002</year>). <article-title>Assessing the emetic potential of PDE4 inhibitors in rats</article-title>. <source>Br. J. Pharmacol.</source> <volume>135</volume>, <fpage>113</fpage>&#x02013;<lpage>118</lpage>. <pub-id pub-id-type="doi">10.1038/sj.bjp.0704457</pub-id><pub-id pub-id-type="pmid">11786486</pub-id></citation>
</ref>
<ref id="B30">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rouch</surname> <given-names>A. J.</given-names></name> <name><surname>Kudo</surname> <given-names>L. H.</given-names></name> <name><surname>H&#x000E9;bert</surname> <given-names>C.</given-names></name></person-group> (<year>1997</year>). <article-title>Dexmedetomidine inhibits osmotic water permeability in the rat cortical collecting duct</article-title>. <source>J. Pharmacol. Exp. Ther.</source> <volume>281</volume>, <fpage>62</fpage>&#x02013;<lpage>69</lpage>. <pub-id pub-id-type="pmid">9103481</pub-id></citation>
</ref>
<ref id="B31">
<citation citation-type="thesis"><person-group person-group-type="author"><name><surname>Satoh</surname> <given-names>K.</given-names></name> <name><surname>Guo</surname> <given-names>M. Y.</given-names></name> <name><surname>Sairenji</surname> <given-names>N.</given-names></name></person-group> (<year>2009</year>). <article-title>Involvement of phosphodiesterase 4 in beta-adrenoceptor agonist-induced amylase release in parotid acinar cells</article-title>. <source>J. Oral Sci.</source> <volume>51</volume>, <fpage>173</fpage>&#x02013;<lpage>179</lpage>. <pub-id pub-id-type="doi">10.2334/josnusd.51.173</pub-id><pub-id pub-id-type="pmid">19550083</pub-id></citation>
</ref>
<ref id="B32">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname> <given-names>J.</given-names></name> <name><surname>Fu</surname> <given-names>G.</given-names></name> <name><surname>Jiang</surname> <given-names>L.</given-names></name> <name><surname>Xu</surname> <given-names>J.</given-names></name> <name><surname>Li</surname> <given-names>L.</given-names></name> <name><surname>Fu</surname> <given-names>G.</given-names></name></person-group> (<year>2013</year>). <article-title>Effect of dexmedetomidine pretreatment on lung injury following intestinal ischemia-reperfusion</article-title>. <source>Exp. Ther. Med.</source> <volume>6</volume>, <fpage>1359</fpage>&#x02013;<lpage>1364</lpage>. <pub-id pub-id-type="doi">10.3892/etm.2013.1317</pub-id><pub-id pub-id-type="pmid">24255662</pub-id></citation>
</ref>
<ref id="B33">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Spachidou</surname> <given-names>M. P.</given-names></name> <name><surname>Bourazopoulou</surname> <given-names>E.</given-names></name> <name><surname>Maratheftis</surname> <given-names>C. I.</given-names></name> <name><surname>Kapsogeorgou</surname> <given-names>E. K.</given-names></name> <name><surname>Moutsopoulos</surname> <given-names>H. M.</given-names></name> <name><surname>Tzioufas</surname> <given-names>A. G.</given-names></name> <etal/></person-group>. (<year>2007</year>). <article-title>Expression of functional Toll-like receptors by salivary gland epithelial cells: increased mRNA expression in cells derived from patients with primary Sjogren&#x00027;s syndrome</article-title>. <source>Clin. Exp. Immunol.</source> <volume>147</volume>, <fpage>497</fpage>&#x02013;<lpage>503</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2249.2006.03311.x</pub-id><pub-id pub-id-type="pmid">17302899</pub-id></citation>
</ref>
<ref id="B34">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname> <given-names>Y.</given-names></name> <name><surname>Gao</surname> <given-names>Q.</given-names></name> <name><surname>Wu</surname> <given-names>N.</given-names></name> <name><surname>Li</surname> <given-names>S. D.</given-names></name> <name><surname>Yao</surname> <given-names>J. X.</given-names></name> <name><surname>Fan</surname> <given-names>W. J.</given-names></name></person-group> (<year>2015</year>). <article-title>Protective effects of dexmedetomidine on intestinal ischemia-reperfusion injury</article-title>. <source>Exp. Ther. Med.</source> <volume>10</volume>, <fpage>647</fpage>&#x02013;<lpage>652</lpage>. <pub-id pub-id-type="doi">10.3892/etm.2015.2561</pub-id><pub-id pub-id-type="pmid">26622369</pub-id></citation>
</ref>
<ref id="B35">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tanabe</surname> <given-names>K.</given-names></name> <name><surname>Matsushima-Nishiwaki</surname> <given-names>R.</given-names></name> <name><surname>Kozawa</surname> <given-names>O.</given-names></name> <name><surname>Iida</surname> <given-names>H.</given-names></name></person-group> (<year>2014</year>). <article-title>Dexmedetomidine suppresses interleukin-1beta-induced interleukin-6 synthesis in rat glial cells</article-title>. <source>Int. J. Mol. Med.</source> <volume>34</volume>, <fpage>1032</fpage>&#x02013;<lpage>1038</lpage>. <pub-id pub-id-type="doi">10.3892/ijmm.2014.1863</pub-id><pub-id pub-id-type="pmid">25069417</pub-id></citation>
</ref>
<ref id="B36">
<citation citation-type="thesis"><person-group person-group-type="author"><name><surname>Tanaka</surname> <given-names>S.</given-names></name> <name><surname>Shimooka</surname> <given-names>S.</given-names></name> <name><surname>Shimomura</surname> <given-names>H.</given-names></name></person-group> (<year>2002</year>). <article-title>Changes in phosphodiesterase activity in the developing rat submandibular gland</article-title>. <source>Arch. Oral Biol.</source> <volume>47</volume>, <fpage>567</fpage>&#x02013;<lpage>576</lpage>. <pub-id pub-id-type="doi">10.1016/S0003-9969(02)00049-3</pub-id><pub-id pub-id-type="pmid">12221013</pub-id></citation>
</ref>
<ref id="B37">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tateishi</surname> <given-names>Y.</given-names></name> <name><surname>Sasabe</surname> <given-names>E.</given-names></name> <name><surname>Ueta</surname> <given-names>E.</given-names></name> <name><surname>Yamamoto</surname> <given-names>T.</given-names></name></person-group> (<year>2008</year>). <article-title>Ionizing irradiation induces apoptotic damage of salivary gland acinar cells via NADPH oxidase 1-dependent superoxide generation</article-title>. <source>Biochem. Biophys. Res. Commun.</source> <volume>366</volume>, <fpage>301</fpage>&#x02013;<lpage>307</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2007.11.039</pub-id><pub-id pub-id-type="pmid">18035043</pub-id></citation>
</ref>
<ref id="B38">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vieceli Dalla Sega</surname> <given-names>F.</given-names></name> <name><surname>Zambonin</surname> <given-names>L.</given-names></name> <name><surname>Fiorentini</surname> <given-names>D.</given-names></name> <name><surname>Rizzo</surname> <given-names>B.</given-names></name> <name><surname>Caliceti</surname> <given-names>C.</given-names></name> <name><surname>Landi</surname> <given-names>L.</given-names></name> <etal/></person-group>. (<year>2014</year>). <article-title>Specific aquaporins facilitate Nox-produced hydrogen peroxide transport through plasma membrane in leukaemia cells</article-title>. <source>Biochim. Biophys. Acta</source> <volume>1843</volume>, <fpage>806</fpage>&#x02013;<lpage>814</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbamcr.2014.01.011</pub-id><pub-id pub-id-type="pmid">24440277</pub-id></citation>
</ref>
<ref id="B39">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Worrell</surname> <given-names>R. T.</given-names></name> <name><surname>Oghene</surname> <given-names>J.</given-names></name> <name><surname>Matthews</surname> <given-names>J. B.</given-names></name></person-group> (<year>2004</year>). <article-title>Ammonium effects on colonic Cl- secretion: anomalous mole fraction behavior</article-title>. <source>Am. J. Physiol. Gastrointest. Liver Physiol.</source> <volume>286</volume>, <fpage>G14</fpage>&#x02013;<lpage>G22</lpage>. <pub-id pub-id-type="doi">10.1152/ajpgi.00196.2003</pub-id><pub-id pub-id-type="pmid">12946942</pub-id></citation>
</ref>
<ref id="B40">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname> <given-names>D.</given-names></name> <name><surname>Hong</surname> <given-names>J. H.</given-names></name></person-group> (<year>2015</year>). <article-title>Dexmedetomidine modulates histamine-induced Ca<sup>2&#x0002B;</sup> signaling and pro-inflammatory cytokine expression</article-title>. <source>Korean J. Physiol. Pharmacol.</source> <volume>19</volume>, <fpage>413</fpage>&#x02013;<lpage>420</lpage>. <pub-id pub-id-type="doi">10.4196/kjpp.2015.19.5.413</pub-id><pub-id pub-id-type="pmid">26330753</pub-id></citation>
</ref>
<ref id="B41">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname> <given-names>D.</given-names></name> <name><surname>Shcheynikov</surname> <given-names>N.</given-names></name> <name><surname>Zeng</surname> <given-names>W.</given-names></name> <name><surname>Ohana</surname> <given-names>E.</given-names></name> <name><surname>So</surname> <given-names>I.</given-names></name> <name><surname>Ando</surname> <given-names>H.</given-names></name> <etal/></person-group>. (<year>2009</year>). <article-title>IRBIT coordinates epithelial fluid and HCO3<sup>&#x02212;</sup> secretion by stimulating the transporters pNBC1 and CFTR in the murine pancreatic duct</article-title>. <source>J. Clin. Invest.</source> <volume>119</volume>, <fpage>193</fpage>&#x02013;<lpage>202</lpage>. <pub-id pub-id-type="doi">10.1172/JCI36983</pub-id><pub-id pub-id-type="pmid">19033647</pub-id></citation>
</ref>
</ref-list>
</back>
</article>